Planned sales, announced before they happen
0 trading plans running, 13 Form 144 notices for $51.3M
Plans running now
0
none adopted and not yet ended or expired
What ABT's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.
Trading plans
Plans adopted or ended
| Insider | What | Date | Shares | Runs to | Reported in |
|---|---|---|---|---|---|
| Hubert L. Allen Executive Vice President, General Counsel and Secretary |
Adopted 10b5-1 plan | May 10, 2024 | up to 157,421 | Feb 19, 2025 | 10-Q Jul 31, 2024 |
What the company wroteOn May 10, 2024, Hubert L. Allen, Executive Vice President, General Counsel and Secretary, adopted a plan for the sale of securities of Abbott that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). Mr. Allen’s Rule 10b5-1 plan provides for the exercise of up to 157,421 stock options until February 19, 2025. | |||||
| Robert E. Funck, Jr. Executive Vice President, Finance |
Adopted 10b5-1 plan | May 10, 2024 | up to 45,000 | Feb 19, 2025 | 10-Q Jul 31, 2024 |
What the company wroteOn May 10, 2024, Robert E. Funck, Jr., the then-Executive Vice President, Finance, adopted a plan for the sale of securities of Abbott that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). Mr. Funck’s Rule 10b5-1 plan provides for the exercise of up to 45,000 stock options until February 19, 2025. | |||||
| Andrea F. Wainer Executive Vice President, Rapid and Molecular Diagnostics |
Adopted 10b5-1 plan | May 1, 2023 | up to 111,606 | 426 days | 10-Q Aug 3, 2023 |
What the company wroteOn May 1, 2023, Andrea F. Wainer, Executive Vice President, Rapid and Molecular Diagnostics, adopted a plan for the sale of securities of Abbott that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). Ms. Wainer's Rule 10b5-1 plan provides for the sale of 5,400 shares and the exercise of up to 111,606 stock options until June 30, 2024. | |||||
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 4, 2023.
Form 144
Notices of planned sales
| Filed | Seller | Shares | Value | Shares came from | 10b5-1 plan | Form 4 sales after |
|---|---|---|---|---|---|---|
| Nov 5, 2026 | Mary K. Moreland Officer |
3,500 | $406K | Restricted Stock Award Vested | none given | 3,500 shares from Nov 5, 2026 |
| Sep 2, 2026 | John A. McCoy, Jr. Officer |
27 | $3K | Restricted Stock Award Vested | none given | 27 shares from Sep 2, 2026 |
| Aug 25, 2026 | Robert B. Ford Officer, Director |
398,832 | $46.2M | Exercise of Stock Options | none given | 398,832 shares from Aug 25, 2026 |
| Aug 11, 2026 | Louis H. Morrone Officer |
5,850 | $643K | Restricted Stock Award Vested | none given | 5,850 shares from Aug 11, 2026 |
| May 15, 2026 | Robert J. Alpern Retired Director |
7,587 | $647K | RSUs Paid In Shares | none given | none found |
| Apr 27, 2026 | Robert J. Alpern Retired Director |
29,211 | $2.7M | Restricted Stock Units | none given | none found |
| Mar 2, 2026 | Elizabeth C. Cushman Officer |
263 | $30K | Restricted Stock Award Vested | none given | none found |
| Mar 2, 2026 | Eric Shroff Officer |
709 | $82K | Restricted Stock Award Vested | none given | none found |
| Mar 2, 2026 | Louis H. Morrone Officer |
1,144 | $132K | Restricted Stock Award Vested | none given | none found |
| Mar 2, 2026 | Mary K. Moreland Officer |
613 | $71K | Restricted Stock Award Vested | none given | none found |
| Mar 2, 2026 | John A. McCoy, Jr. Officer |
585 | $68K | Restricted Stock Award Vested | none given | none found |
| Mar 2, 2026 | Daniel Gesua Sive Salvadori Officer |
885 | $102K | Restricted Stock Award Vested | none given | none found |
| Nov 25, 2025 | Eric Shroff Officer |
1,586 | $203K | Restricted Stock Award Vested | none given | none found |
Show the other 5 notices
From the Form 144 XML filed with the SEC, since Nov 25, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.